Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers

被引：0
|
作者：
Neda Stjepanovic
Jan Lubinski
Pal Moller
Susan Randall Armel
William D. Foulkes
Nadine Tung
Susan L. Neuhausen
Joanne Kotsopoulos
Ping Sun
Sophie Sun
Andrea Eisen
Steven A. Narod
机构：
[1] Toronto-Sunnybrook Regional Cancer Center,Department of Genetics and Pathology, International Hereditary Cancer Center
[2] Pomeranian Medical University,Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital
[3] Oslo University Hospital,Program in Cancer Genetics, Department of Oncology and Human Genetics
[4] University Health Network,Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences
[5] McGill University,Dalla Lana School of Public Health
[6] Beth Israel Deaconess Medical Center,undefined
[7] City of Hope,undefined
[8] Women’s College Research Institute,undefined
[9] Women’s College Hospital,undefined
[10] University of Toronto,undefined
[11] BC Cancer Agency,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
BRCA1; BRCA2; Prospective; Incidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 523
页数：8
相关论文
共 50 条
  • [31] Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Jane C. Figueiredo
    Robert W. Haile
    Jonine L. Bernstein
    Current Breast Cancer Reports, 2009, 1 (3) : 139 - 147
  • [32] Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Oden, Lovisa
    Akbari, Mohammad
    Zaman, Tasnim
    Singer, Christian F.
    Sun, Ping
    Narod, Steven A.
    Salmena, Leonardo
    Kotsopoulos, Joanne
    ONCOTARGET, 2016, 7 (52) : 86687 - 86694
  • [33] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Narod, SA
    Dubé, MP
    Klijn, J
    Lubinski, J
    Lynch, HT
    Ghadirian, P
    Provencher, D
    Heimdal, K
    Moller, P
    Robson, M
    Offit, K
    Isaacs, C
    Weber, B
    Friedman, E
    Gershoni-Baruch, R
    Rennert, G
    Pasini, B
    Wagner, T
    Daly, M
    Garber, JE
    Neuhausen, SL
    Ainsworth, P
    Olsson, H
    Evans, G
    Osborne, M
    Couch, F
    Foulkes, WD
    Warner, E
    Kim-Sing, C
    Olopade, O
    Tung, N
    Saal, HM
    Weitzel, J
    Merajver, S
    Gauthier-Villars, M
    Jernstrom, H
    Sun, P
    Brunet, JS
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (23): : 1773 - 1779
  • [34] Oral Contraceptives and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Figueiredo, Jane C.
    Haile, Robert W.
    Bernstein, Jonine L.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 139 - 147
  • [35] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099
  • [36] Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Mitchell, G
    Antoniou, AC
    Warren, R
    Peock, S
    Brown, J
    Davies, R
    Mattison, J
    Cook, M
    Warsi, I
    Evans, DG
    Eccles, D
    Douglas, F
    Paterson, J
    Hodgson, S
    Izatt, L
    Cole, T
    Burgess, L
    Eeles, R
    Easton, DF
    CANCER RESEARCH, 2006, 66 (03) : 1866 - 1872
  • [37] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [38] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [39] Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Jernström, H
    Lubinski, J
    Lynch, HT
    Ghadirian, P
    Neuhausen, S
    Isaacs, C
    Weber, BL
    Horsman, D
    Rosen, B
    Foulkes, WD
    Friedman, E
    Gershoni-Baruch, R
    Ainsworth, P
    Daly, M
    Garber, J
    Olsson, H
    Sun, P
    Narod, SA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (14): : 1094 - 1098
  • [40] Cancer risks among BRCA1 and BRCA2 mutation carriers
    E Levy-Lahad
    E Friedman
    British Journal of Cancer, 2007, 96 : 11 - 15
12345